| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_337c0227a9ebfe9031dad43547af607e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9aaeeefb34ead0abb5765c4c2fee2b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6063fbefd325c93a8f276e12a263a790
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc4393a89e10becae664691684584f5c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D301-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C201-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C201-12 |
| filingDate |
2009-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3a1916e4c898bc710c09895fe85b93b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320746ee7729dfea7eaf2b0be2123dd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6035e7846674656bd760f940b668c38 |
| publicationDate |
2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010128355-A3 |
| titleOfInvention |
Improved processes for preparing substantially pure arformoterol and its intermediates |
| abstract |
Provided herein are improved, convenient and industrially advantageous processes for the preparation of N-[2-hydroxy-5-[(1R)-l-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1- methylethyl] amino]ethyl]phenyl]formamide (Arformoterol) or a pharmaceutically acceptable salt thereof, in high yield and purity. Provided further herein is an improved and industrially advantageous process for the preparation of a substantially enantiomerically pure arformoterol intermediate, (R)-4-methoxy-α-methyl-N-(phenylmethyl)benzeneethanamine. |
| priorityDate |
2008-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |